Thursday, May 27, 2021

Inhaled nanobodies protect hamsters from COVID-19, study finds

Inhalable nanobodies targeting the spike protein of SARS-CoV-2 can prevent and treat severe COVID-19 in hamsters, according to new research.

from Top Health News -- ScienceDaily https://ift.tt/3yLRaf1

No comments:

Post a Comment

FDA clears IND for clinical trial testing switchable CAR-T therapy in patients with autoimmune diseases, without chemotherapy

FDA has cleared an investigational new drug (IND) application to study switchable chimeric antigen receptor T cell (sCAR-T) therapy (CLBR001...